Skip to main content

Advertisement

Table 3 Correlation between hTR, hTERT and clinicopathological parameters

From: The expression of hTR and hTERT in human breast cancer: correlation with clinico-pathological parameters

Parameter Freq        hTERT+ samples
    hTR expression hTERT expression hTR expression
    Neg. Pos. P Neg. Pos. P Neg. Pos P
Age range ≤40
>40
10 (22.2)*
35 (77.8)
0
14
10
21
0.019 0
8
10
27
0.168 0
11
10
16
0.018
Size range ≤2 cm 22 (47.8) 5 17 0.2 4 18 0.538 4 14 0.27
  2–5 cm 19 (41.3) 9 10   4 15   7 8  
  >5 cm 5 (10.8) 1 4   0 5   1 4  
Pathol. IDC 43 (95.5) 15 28 0.593 8 35 0.798 12 23 0.602
  ILC 1 (2.2) 0 1   0 1   0 1  
  Muc. 1 (2.2) 0 1   0 1   0 1  
Grade I 4 (9.8) 1 3 0.282 1 3 0.958 1 2 0.765
  II 16 (39) 3 13   3 13   3 10  
  III 21 (51.2) 9 12   4 17   6 11  
  Low 20 (48.8) 4 16 0.18 4 16 1 4 12 0.7
  High 20 (51.2) 9 12   4 17   6 11  
ALN Inv. Positive 26 (57.8) 6 20 0.2 4 22 0.7 5 17 0.29
  Negative 19 (42.2) 8 11   4 15   6 9  
Stage I 9 (30) 4 5 0.087 2 7 0.941 3 4 0.045
  IIA 7 (23.3) 2 5   2 5   1 4  
  IIB 7 (23.3) 5 2   1 6   5 1  
  IIIA 6 (20) 0 6   1 5   0 5  
  IIIB 1 (3.3) 0 1   0 1   0 1